KEGG   DISEASE: Ehlers-Danlos syndrome (EDS)Help
H00802                      Disease                                

Ehlers-Danlos syndrome (EDS), including:
EDS classical type (EDS1/2);
EDS hypermobility type (EDS3);
EDS vascular type (EDS4);
EDS kyphoscoliosis type (EDS6);
EDS arthrochalasia type (EDS7A/7B);
EDS dermatospraxis type (EDS7C);
EDS autosomal recessive cardiac valvular form (EDSCV);
EDS musculocontractural type (EDSMC);
EDS progeroid form (EDSP);
Tenascin-X deficiency (TNXD);
Brittle cornea syndrome (EDS6B);
EDS-like spondylocheiro dysplasia (SCD-EDS)
Ehlers-Danlos syndrome (EDS) is an inherited heterogeneous group of connective tissue disorders, characterized by abnormal collagen synthesis, affecting skin, ligaments, joints, blood vessels and other organs. Most EDS subtypes are caused by mutations in genes encoding the fibrillar collagens type I, III and V, or in genes coding for enzymes involved in the post-translational modification of these collagens. EDS can be classified  into six major types: classical type, hypermobility type, vascular type, kyphoscoliosis type, arthrochalasia type and dermatospraxis type. Additional minor variants of EDS have been identified with molecular and biochemical abnormalities: cardiac valvular form, musculocontractural type, progeroid form, tenascin-X deficiency, Brittle cornea syndrome, and EDS-like spondylocheiro dysplasia.
Inherited metabolic disease; Connective tissue disease
Human diseases [BR:br08402]
 Other congenital disorders
  Congenital disorders of development
   H00802  Ehlers-Danlos syndrome (EDS)
Human diseases in ICD-10 classification [BR:br08403]
 17. Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  Q65-Q79  Congenital malformations and deformations of the musculoskeletal system
   Q79  Congenital malformations of the musculoskeletal system, not elsewhere classified
    H00802  Ehlers-Danlos syndrome (EDS)
BRITE hierarchy
Focal adhesion  
ECM-receptor interaction  
Lysine degradation
Glycosaminoglycan biosynthesis - chondroitin sulfate
Glycosaminoglycan biosynthesis - heparan sulfate
(EDS1/7A) COL1A1 [HSA:1277] [KO:K06236]
(EDS7B/CV) COL1A2 [HSA:1278] [KO:K06236]
(EDS3/4) COL3A1 [HSA:1281] [KO:K19720]
(EDS1/2) COL5A1 [HSA:1289] [KO:K19721]
(EDS1) COL5A2 [HSA:1290] [KO:K19721]
(EDS6) PLOD [HSA:5351] [KO:K00473]
(EDS7C) ADAMTS2 [HSA:9509] [KO:K08618]
(EDSMC) CHST14 [HSA:113189] [KO:K08105]
(EDSP1) B4GALT7 [HSA:11285] [KO:K00733]
(EDSP2) B3GALT6 [HSA:126792] [KO:K00734]
(TNXD) TNXB [HSA:7148] [KO:K06252]
(EDS6B) ZNF469 [HSA:84627]
(SCD-EDS) SLC39A13 [HSA:91252] [KO:K14719]
Other DBs
Parapia LA, Jackson C
Ehlers-Danlos syndrome--a historical review.
Br J Haematol 141:32-5 (2008)
De Paepe A, Malfait F
Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen  vascular disorders.
Br J Haematol 127:491-500 (2004)
Kosho T, Miyake N, Hatamochi A, Takahashi J, Kato H, Miyahara T, Igawa Y, Yasui H, Ishida T, Ono K, Kosuda T, Inoue A, Kohyama M, Hattori T, Ohashi H, Nishimura G, Kawamura R, Wakui K, Fukushima Y, Matsumoto N
A new Ehlers-Danlos syndrome with craniofacial characteristics, multiple congenital contractures, progressive joint and skin laxity, and multisystem fragility-related manifestations.
Am J Med Genet A 152A:1333-46 (2010)
Nakajima M, Mizumoto S, Miyake N, Kogawa R, Iida A, Ito H, Kitoh H, Hirayama A, Mitsubuchi H, Miyazaki O, Kosaki R, Horikawa R, Lai A, Mendoza-Londono R, Dupuis L, Chitayat D, Howard A, Leal GF, Cavalcanti D, Tsurusaki Y, Saitsu H, Watanabe S, Lausch E, Unger S, Bonafe L, Ohashi H, Superti-Furga A, Matsumoto N, Sugahara K, Nishimura G, Ikegawa S
Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders.
Am J Hum Genet 92:927-34 (2013)

» Japanese version

DBGET integrated database retrieval system